Priority list of potential endocrine-disrupting chemicals in food chemical contaminants: a docking study and in vitro/epidemiological evidence integration

References

• L. Connolly, E. Ropstad, and S. Verhaegen, In vitro bioassays for the study of endocrine-disrupting food additives and contaminants, Trends Anal. Chem. 30 (2011), pp. 227–238. doi:10.1016/j.trac.2010.10.009.
   Web of Science ®Google Scholar
• M. Di Criscio, J.E. Lodahl, A. Stamatakis, E. Kitraki, I. Bakoyiannis, A. Repouskou, C.-G. Bornehag, C. Gennings, D. Lupu, and J. Rüegg, A human-relevant mixture of endocrine disrupting chemicals induces changes in hippocampal DNA methylation correlating with hyperactive behavior in male mice, Chemosphere 313 (2023), pp. 137633. doi:10.1016/j.chemosphere.2022.137633.
   PubMed Web of Science ®Google Scholar
• E.C. Plunk and S.M. Richards, Endocrine-disrupting air pollutants and their effects on the hypothalamus-pituitary-gonadal axis, Int. J. Mol. Sci. 21 (2020), pp. 9191. doi:10.3390/ijms21239191.
   PubMed Web of Science ®Google Scholar
• A.D. Benninghoff, W.H. Bisson, D.C. Koch, D.J. Ehresman, S.K. Kolluri, and D.E. Williams, Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro, Toxicol. Sci. 120 (2011), pp. 42–58. doi:10.1093/toxsci/kfq379.
   PubMed Web of Science ®Google Scholar
• B. Lal, M.K. Sarang, and P. Kumar, Malathion exposure induces the endocrine disruption and growth retardation in the catfish, Clarias batrachus (Linn.), Gen. Comp. Endocrinol. 181 (2013), pp. 139–145. doi:10.1016/j.ygcen.2012.11.004.
   PubMed Web of Science ®Google Scholar
• S. Lecomte, F. Demay, T.H. Pham, S. Moulis, T. Efstathiou, F. Chalmel, and F. Pakdel, Deciphering the molecular mechanisms sustaining the estrogenic activity of the two major dietary compounds zearalenone and apigenin in ER-positive breast cancer cell lines, Nutrients 11 (2019), pp. 237. doi:10.3390/nu11020237.
   PubMed Web of Science ®Google Scholar
• J.W. Lee, K. Choi, K. Park, C. Seong, S.D. Yu, and P. Kim, Adverse effects of perfluoroalkyl acids on fish and other aquatic organisms: A review, Sci. Tot. Environ. 707 (2020), pp. 135334. doi:10.1016/j.scitotenv.2019.135334.
   PubMed Web of Science ®Google Scholar
• J.R. Rochester, Bisphenol A and human health: A review of the literature, Reprod. Toxicol. 42 (2013), pp. 132–155. doi:10.1016/j.reprotox.2013.08.008.
   PubMed Web of Science ®Google Scholar
• P. Tomkins, M. Saaristo, M. Allinson, and B.B.M. Wong, Exposure to an agricultural contaminant, 17β-trenbolone, impairs female mate choice in a freshwater fish, Aquatic Toxicol. 170 (2016), pp. 365–370. doi:10.1016/j.aquatox.2015.09.019.
   PubMed Web of Science ®Google Scholar
• M.I. Ahmad, A. Usman, and M. Ahmad, Computational study involving identification of endocrine disrupting potential of herbicides: Its implication in TDS and cancer progression in CRPC patients, Chemosphere 173 (2017), pp. 395–403. doi:10.1016/j.chemosphere.2017.01.054.
   PubMed Web of Science ®Google Scholar
• J. Devillers, E. Bro, and F. Millot, Prediction of the endocrine disruption profile of pesticides, SAR QSAR Environ. Res. 26 (2015), pp. 831–852. doi:10.1080/1062936x.2015.1104809.
   PubMed Web of Science ®Google Scholar
• C. Song, Q. Wu, J. Sun, R. Zhang, J. Chen, X. Wang, L. Fang, Z. Liu, X. Shan, and Y. Yin, In silico evaluation of interactions between antibiotics in aquaculture and nuclear hormone receptors, Aquacult. Env. Interac. 13 (2021), pp. 389–397. doi:10.3354/aei00414.
   Web of Science ®Google Scholar
• S. Yu, J. Ren, Z. Lv, R. Li, Y. Zhong, W. Yao, and J. Yuan, Prediction of the endocrine-disrupting ability of 49 per- and polyfluoroalkyl substances: In silico and epidemiological evidence, Chemosphere 290 (2022), pp. 133366. doi:10.1016/j.chemosphere.2021.133366.
   PubMed Web of Science ®Google Scholar
• OECD, Revised Guidance Document 150 on Standardised test Guidelines for Evaluating Chemicals for Endocrine Disruption, No. 150, OECD Series on Testing and Assessment, OECD Publishing, Paris, 2018.
   Google Scholar
• D. Trisciuzzi, D. Alberga, K. Mansouri, R. Judson, S. Cellamare, M. Catto, A. Carotti, E. Benfenati, E. Novellino, G.F. Mangiatordi, and O. Nicolotti, Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data, Future Med. Chem. 7 (2015), pp. 1921–1936. doi:10.4155/fmc.15.103.
   PubMed Web of Science ®Google Scholar
• K. Mansouri, A. Abdelaziz, A. Rybacka, A. Roncaglioni, A. Tropsha, A. Varnek, A. Zakharov, A. Worth, M. Richard Ann, M. Grulke Christopher, D. Trisciuzzi, D. Fourches, D. Horvath, E. Benfenati, E. Muratov, B. Wedebye Eva, F. Grisoni, F. Mangiatordi Giuseppe, M. Incisivo Giuseppina, H. Hong, W. Ng Hui, V. Tetko Igor, I. Balabin, J. Kancherla, J. Shen, J. Burton, M. Nicklaus, M. Cassotti, G. Nikolov Nikolai, O. Nicolotti, L. Andersson Patrik, Q. Zang, R. Politi, D. Beger Richard, R. Todeschini, R. Huang, S. Farag, A. Rosenberg Sine, S. Slavov, X. Hu, and S. Judson Richard, CERAPP: Collaborative estrogen receptor activity prediction project, Environ. Health Perspect. 124 (2016), pp. 1023–1033. doi:10.1289/ehp.1510267.
   PubMed Web of Science ®Google Scholar
• K. Kolšek, J. Mavri, M. Sollner Dolenc, S. Gobec, and S. Turk, Endocrine Disruptome—An open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding, J. Chem. Inf. Model. 54 (2014), pp. 1254–1267. doi:10.1021/ci400649p.
   PubMed Web of Science ®Google Scholar
• O. Trott and A.J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem. 31 (2010), pp. 455–461. doi:10.1002/jcc.21334.
   PubMed Web of Science ®Google Scholar
• E. Diamanti-Kandarakis, J.P. Bourguignon, L.C. Giudice, R. Hauser, G.S. Prins, A.M. Soto, R.T. Zoeller, and A.C. Gore, Endocrine-disrupting chemicals: An endocrine society scientific statement, Endocr. Rev. 30 (2009), pp. 293–342. doi:10.1210/er.2009-0002.
   PubMed Web of Science ®Google Scholar
• F. Grün and B. Blumberg, Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling, Endocrinology 147 (2006), pp. S50–S55. doi:10.1210/en.2005-1129.
   PubMed Web of Science ®Google Scholar
• L.K. Akinola, A. Uzairu, G.A. Shallangwa, and S.E. Abechi, Theoretical study on endocrine disrupting effects of polychlorinated dibenzo-p-dioxins using molecular docking simulation, J. Appl. Toxicol. 41 (2021), pp. 233–246. doi:10.1002/jat.4039.
   PubMed Web of Science ®Google Scholar
• A. Plošnik, M. Vračko, and J. Mavri, Computational study of binding affinity to nuclear receptors for some cosmetic ingredients, Chemosphere 135 (2015), pp. 325–334. doi:10.1016/j.chemosphere.2015.04.075.
   PubMed Web of Science ®Google Scholar
• A. Usman and M. Ahmad, Computational study suggesting reconsideration of BPA analogues based on their endocrine disrupting potential estimated by binding affinities to nuclear receptors, Ecotoxicol. Environ. Saf. 171 (2019), pp. 154–161. doi:10.1016/j.ecoenv.2018.12.071.
   PubMed Web of Science ®Google Scholar
• X. Wang, R. Zhang, C. Song, and D. Crump, Computational evaluation of interactions between organophosphate esters and nuclear hormone receptors, Environ. Res. 182 (2020), pp. 108982. doi:10.1016/j.envres.2019.108982.
   PubMed Web of Science ®Google Scholar
• Y. Zhong, J. Ren, R. Li, Y. Xuan, W. Yao, Q. Yang, Y. Gan, S. Yu, and J. Yuan, Prediction of the endocrine disruption profile of fluorinated biphenyls and analogues: An in silico study, Chemosphere 314 (2023), pp. 137701. doi:10.1016/j.chemosphere.2022.137701.
   PubMed Web of Science ®Google Scholar
• P. Pérez-Ortega, F.J. Lara-Ortega, B. Gilbert-López, D. Moreno-González, J.F. García-Reyes, and A. Molina-Díaz, Screening of over 600 pesticides, veterinary drugs, food-packaging contaminants, mycotoxins, and other chemicals in food by ultra-high performance liquid chromatography quadrupole time-of-flight mass spectrometry (UHPLC-QTOFMS), Food Anal. Method. 10 (2017), pp. 1216–1244. doi:10.1007/s12161-016-0678-0.
   Web of Science ®Google Scholar
• P. Ruiz, A. Sack, M. Wampole, S. Bobst, and M. Vracko, Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors, Chemosphere 178 (2017), pp. 99–109. doi:10.1016/j.chemosphere.2017.03.026.
   PubMed Web of Science ®Google Scholar
• A.J. Williams, C.M. Grulke, J. Edwards, A.D. McEachran, K. Mansouri, N.C. Baker, G. Patlewicz, I. Shah, J.F. Wambaugh, R.S. Judson, and A.M. Richard, The CompTox chemistry dashboard: A community data resource for environmental chemistry, J. Cheminform. 9 (2017), pp. 61. doi:10.1186/s13321-017-0247-6.
   PubMed Web of Science ®Google Scholar
• A.P. Davis, T.C. Wiegers, R.J. Johnson, D. Sciaky, J. Wiegers, and C.J. Mattingly, Comparative toxicogenomics database (CTD): Update 2023, Nucleic Acids Res. 51 (2023), pp. D1257–D1262. doi:10.1093/nar/gkac833.
   PubMed Web of Science ®Google Scholar
• S. Kim, J. Chen, T. Cheng, A. Gindulyte, J. He, S. He, Q. Li, B.A. Shoemaker, P.A. Thiessen, B. Yu, L. Zaslavsky, J. Zhang, and E.E. Bolton, PubChem in 2019: New data content and improved web interfaces, Nucleic Acids Res. 49 (2021), pp. D1388–D1395. doi:10.1093/nar/gkaa971.
   PubMed Web of Science ®Google Scholar
• G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J. Comput. Chem. 30 (2009), pp. 2785–2791. doi:10.1002/jcc.21256.
   PubMed Web of Science ®Google Scholar
• T.A. Blizzard, F. DiNinno, J.D. Morgan, H.Y. Chen, J.Y. Wu, S. Kim, W. Chan, E.T. Birzin, Y.T. Yang, L.-Y. Pai, P.M.D. Fitzgerald, N. Sharma, Y. Li, Z. Zhang, E.C. Hayes, C.A. DaSilva, W. Tang, S.P. Rohrer, J.M. Schaeffer, and M.L. Hammond, Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers, Bioorg. Med. Chem. Lett. 15 (2005), pp. 107–113. doi:10.1016/j.bmcl.2004.10.036.
   PubMed Web of Science ®Google Scholar
• C.B. Duke III, A. Jones, C.E. Bohl, J.T. Dalton, and D.D. Miller, Unexpected binding orientation of bulky-b-ring anti-androgens and implications for future drug targets, J. Med. Chem. 54 (2011), pp. 3973–3976. doi:10.1021/jm2000097.
   PubMed Web of Science ®Google Scholar
• T. Hasui, N. Matsunaga, T. Ora, N. Ohyabu, N. Nishigaki, Y. Imura, Y. Igata, H. Matsui, T. Motoyaji, T. Tanaka, N. Habuka, S. Sogabe, M. Ono, C.S. Siedem, T.P. Tang, C. Gauthier, L.A. De Meese, S.A. Boyd, and S. Fukumoto, Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists, J. Med. Chem. 54 (2011), pp. 8616–8631. doi:10.1021/jm2011645.
   PubMed Web of Science ®Google Scholar
• A.K. Shiau, D. Barstad, J.T. Radek, M.J. Meyers, K.W. Nettles, B.S. Katzenellenbogen, J.A. Katzenellenbogen, D.A. Agard, and G.L. Greene, Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism, Nat. Struct. Biol. 9 (2002), pp. 359–364. doi:10.1038/nsb787.
   PubMedGoogle Scholar
• A.C. Wallace, R.A. Laskowski, and J.M. Thornton, LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions, Protein Eng. Des. Sel. 8 (1995), pp. 127–134. doi:10.1093/protein/8.2.127.
   Web of Science ®Google Scholar
• S. Agarwal, A. Dixit, and S.K. Kashaw, Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies, J. Mol. Graph. Model. 98 (2020), pp. 107591. doi:10.1016/j.jmgm.2020.107591.
   PubMed Web of Science ®Google Scholar
• G. Auzou, J. Fagart, A. Souque, C. Hellal-Lévy, J.-M. Wurtz, D. Moras, and M.-E. Rafestin-Oblin, A single amino acid mutation of Ala-773 in the mineralocorticoid receptor confers agonist properties to 11β-substituted spirolactones, Mol. Pharmacol. 58 (2000), pp. 684–691. doi:10.1124/mol.58.4.684.
   PubMed Web of Science ®Google Scholar
• J. Fagart, C. Seguin, G.M. Pinon, and M.-E. Rafestin-Oblin, The Met852 residue is a key organizer of the ligand-binding cavity of the human mineralocorticoid receptor, Mol. Pharmacol. 67 (2005), pp. 1714. doi:10.1124/mol.104.010710.
   PubMed Web of Science ®Google Scholar
• J. Fagart, J.M. Wurtz, A. Souque, C. Hellal-Levy, D. Moras, and M.E. Rafestin-Oblin, Antagonism in the human mineralocorticoid receptor, EMBO J. 17 (1998), pp. 3317–3325. 10.1093/emboj/17.12.3317.
   PubMed Web of Science ®Google Scholar
• S.R. Lee, Y.J. Park, Y.B. Han, J.C. Lee, S. Lee, H.-J. Park, H.-J. Lee, and K.H. Kim, Isoamericanoic acid B from Acer tegmentosum as a potential phytoestrogen, Nutrients 10 (2018), pp. 1915. doi:10.3390/nu10121915.
   PubMed Web of Science ®Google Scholar
• M. Rehan, E. Ahmad, and M.A. Beg, Structural binding perspectives of a major tobacco alkaloid, nicotine, and its metabolite cotinine with sex-steroid nuclear receptors, J. Appl. Toxicol. 40 (2020), pp. 1410–1420. doi:10.1002/jat.3993.
   PubMed Web of Science ®Google Scholar
• G. Shao, J. Bao, X. Pan, X. He, Y. Qi, and J.Z.H. Zhang, Computational analysis of residue-specific binding free energies of androgen receptor to ligands, Front. Mol. Biosci. 8 (2021), pp. 646524. 10.3389/fmolb.2021.646524.
   PubMed Web of Science ®Google Scholar
• L.C. Alonso and R.L. Rosenfield, Oestrogens and puberty, Best Pract. Res. Clin. Endocrinol. Metab. 16 (2002), pp. 13–30. doi:10.1053/beem.2002.0177.
   PubMed Web of Science ®Google Scholar
• R.A. Rey, The role of androgen signaling in male sexual development at puberty, Endocrinology 162 (2020), pp. 1–16. doi:10.1210/endocr/bqaa215.
   Web of Science ®Google Scholar
• S.L. Kristensen, C.H. Ramlau-Hansen, E. Ernst, S.F. Olsen, J.P. Bonde, A. Vested, T.I. Halldorsson, G. Becher, L.S. Haug, and G. Toft, Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction, Hum. Reprod. 28 (2013), pp. 3337–3348. doi:10.1093/humrep/det382.
   PubMed Web of Science ®Google Scholar
• A. Ernst, N. Brix, L.L.B. Lauridsen, J. Olsen, E.T. Parner, Z. Liew, L.H. Olsen, and C.H. Ramlau-Hansen, Exposure to perfluoroalkyl substances during fetal life and pubertal development in boys and girls from the Danish national birth cohort, Environ. Health Perspect. 127 (2019), pp. 017004. doi:10.1289/EHP3567.
   PubMed Web of Science ®Google Scholar
• G.L. Bakris, R. Agarwal, S.D. Anker, B. Pitt, L.M. Ruilope, P. Rossing, P. Kolkhof, C. Nowack, P. Schloemer, A. Joseph, G. Filippatos, and F.-D. Investigators, Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes, N. Engl. J. Med. 383 (2020), pp. 2219–2229. doi:10.1056/NEJMoa2025845.
   PubMed Web of Science ®Google Scholar
• A.P. Davel, I.J. Anwar, and I.Z. Jaffe, The endothelial mineralocorticoid receptor: Mediator of the switch from vascular health to disease, Curr. Opin. Nephrol. Hypertens. 26 (2017), pp. 97–104. doi:10.1097/MNH.0000000000000306.
   PubMed Web of Science ®Google Scholar
• V. Patel, A. Joharapurkar, and M. Jain, Role of mineralocorticoid receptor antagonists in kidney diseases, Drug Dev. Res. 82 (2021), pp. 341–363. doi:10.1002/ddr.21760.
   PubMed Web of Science ®Google Scholar
• S.V. Shenoy, S.P. Nagaraju, M.V. Bhojaraja, R.A. Prabhu, D. Rangaswamy, and I.R. Rao, Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade, Nephrology 26 (2021), pp. 858–871. doi:10.1111/nep.13917.
   PubMed Web of Science ®Google Scholar
• M. Thuzar and M. Stowasser, The mineralocorticoid receptor—An emerging player in metabolic syndrome?, J. Hum. Hypertens. 35 (2021), pp. 117–123. doi:10.1038/s41371-020-00467-3.
   PubMed Web of Science ®Google Scholar
• D.J. Watkins, J. Josson, B. Elston, S.M. Bartell, H.M. Shin, V.M. Vieira, D.A. Savitz, T. Fletcher, and G.A. Wellenius, Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant, Environ. Health Perspect. 121 (2013), pp. 625–630. doi:10.1289/ehp.1205838.
   PubMed Web of Science ®Google Scholar
• X.D. Qin, Z. Qian, M.G. Vaughn, J. Huang, P. Ward, X.W. Zeng, Y. Zhou, Y. Zhu, P. Yuan, M. Li, Z. Bai, G. Paul, Y.T. Hao, W. Chen, P.C. Chen, G.H. Dong, and Y.L. Lee, Positive associations of serum perfluoroalkyl substances with uric acid and hyperuricemia in children from Taiwan, Environ. Pollut. 212 (2016), pp. 519–524. doi:10.1016/j.envpol.2016.02.050.
   PubMed Web of Science ®Google Scholar
• M. Spatlen, F. Perera, S. Lederman, M. Robinson, K. Kannan, J. Herbstman, and L. Trasande, The association between perfluoroalkyl substances and lipids in cord blood, Environ. Epidemiol. 3 (2019), pp. 43–54. doi:10.1210/clinem/dgz024.
   Google Scholar
• A.P. Starling, C. Liu, G. Shen, I.V. Yang, K. Kechris, S.J. Borengasser, K.E. Boyle, W. Zhang, H.A. Smith, A.M. Calafat, R.F. Hamman, J.L. Adgate, and D. Dabelea, Prenatal exposure to per- and polyfluoroalkyl substances, umbilical cord blood DNA methylation, and cardio-metabolic indicators in newborns: The healthy start study, Environ. Health Perspect. 128 (2020), pp. 127014. doi:10.1289/EHP6888.
   PubMed Web of Science ®Google Scholar
• R.B. Jain and A. Ducatman, Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6–11 years, Environ. Pollut. 243 (2018), pp. 1–8. doi:10.1016/j.envpol.2018.08.060.
   PubMed Web of Science ®Google Scholar
• M.S. Bloom, S. Commodore, P.L. Ferguson, B. Neelon, J.L. Pearce, A. Baumer, R.B. Newman, W. Grobman, A. Tita, J. Roberts, D. Skupski, K. Palomares, M. Nageotte, K. Kannan, C. Zhang, R. Wapner, J.E. Vena, and K.J. Hunt, Association between gestational PFAS exposure and children’s adiposity in a diverse population, Environ. Res. 203 (2022), pp. 111820. doi:10.1016/j.envres.2021.111820.
   PubMed Web of Science ®Google Scholar
• J.M. Braun, A. Chen, M.E. Romano, A.M. Calafat, G.M. Webster, K. Yolton, and B.P. Lanphear, Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study, Obesity (Silver Spring) 24 (2016), pp. 231–237. doi:10.1002/oby.21258.
   PubMed Web of Science ®Google Scholar
• M. Maisonet, M.L. Terrell, M.A. McGeehin, K.Y. Christensen, A. Holmes, A.M. Calafat, and M. Marcus, Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls, Environ. Health Perspect. 120 (2012), pp. 1432–1437. doi:10.1289/ehp.1003096.
   PubMed Web of Science ®Google Scholar
• S. Itoh, K. Yamazaki, S. Suyama, A. Ikeda-Araki, C. Miyashita, Y. Ait Bamai, S. Kobayashi, H. Masuda, T. Yamaguchi, H. Goudarzi, E. Okada, I. Kashino, T. Saito, and R. Kishi, The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study, Environ. Int. 159 (2022), pp. 107026. doi:10.1016/j.envint.2021.107026.
   PubMed Web of Science ®Google Scholar
• Q. Yao, A. Vinturache, X. Lei, Z. Wang, C. Pan, R. Shi, T. Yuan, Y. Gao, and Y. Tian, Prenatal exposure to per- and polyfluoroalkyl substances, fetal thyroid hormones, and infant neurodevelopment, Environ. Res. 206 (2022), pp. 112561. doi:10.1016/j.envres.2021.112561.
   PubMed Web of Science ®Google Scholar
• F. Coperchini, O. Awwad, M. Rotondi, F. Santini, M. Imbriani, and L. Chiovato, Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA), J. Endocrinol. Invest. 40 (2017), pp. 105–121. doi:10.1007/s40618-016-0572-z.
   PubMed Web of Science ®Google Scholar
• F. Coperchini, L. Croce, G. Ricci, F. Magri, M. Rotondi, M. Imbriani, and L. Chiovato, Thyroid disrupting effects of old and new generation PFAS, Front. Endocrinol. 11 (2020), pp. 612320. doi:10.3389/fendo.2020.612320.
   PubMed Web of Science ®Google Scholar
• V. Ballesteros, O. Costa, C. Iñiguez, T. Fletcher, F. Ballester, and M.-J. Lopez-Espinosa, Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies, Environ. Int. 99 (2017), pp. 15–28. doi:10.1016/j.envint.2016.10.015.
   PubMed Web of Science ®Google Scholar
• E.V. Preston, T.F. Webster, E. Oken, B. Claus Henn, M.D. McClean, S.L. Rifas-Shiman, E.N. Pearce, L.E. Braverman, A.M. Calafat, X. Ye, and S.K. Sagiv, Maternal plasma per- and polyfluoroalkyl substance concentrations in early pregnancy and maternal and neonatal thyroid function in a prospective birth cohort: Project Viva (USA), Environ. Health Perspect. 126 (2018), pp. 027013. doi:10.1289/ehp2534.
   PubMed Web of Science ®Google Scholar
• E.V. Preston, T.F. Webster, B. Claus Henn, M.D. McClean, C. Gennings, E. Oken, S.L. Rifas-Shiman, E.N. Pearce, A.M. Calafat, A.F. Fleisch, and S.K. Sagiv, Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva cohort: A mixtures approach, Environ. Int. 139 (2020), pp. 105728. doi:10.1016/j.envint.2020.105728.
   PubMed Web of Science ®Google Scholar
• S. Kim, K. Choi, K. Ji, J. Seo, Y. Kho, J. Park, S. Kim, S. Park, I. Hwang, J. Jeon, H. Yang, and J.P. Giesy, Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones, Environ. Sci. Technol. 45 (2011), pp. 7465–7472. doi:10.1021/es202408a.
   PubMed Web of Science ®Google Scholar
• M.-J. Lopez-Espinosa, D. Mondal, B. Armstrong, M.S. Bloom, and T. Fletcher, Thyroid function and perfluoroalkyl acids in children living near a chemical plant, Environ. Health Perspect. 120 (2012), pp. 1036–1041. doi:10.1289/ehp.1104370.
   PubMed Web of Science ®Google Scholar
• A.M. Vuong, G.M. Webster, K. Yolton, A.M. Calafat, G. Muckle, B.P. Lanphear, and A. Chen, Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study, Environ. Res. 195 (2021), pp. 110825. doi:10.1016/j.envres.2021.110825.
   PubMed Web of Science ®Google Scholar
• J. Oh, D.H. Bennett, A.M. Calafat, D. Tancredi, D.L. Roa, R.J. Schmidt, I. Hertz-Picciotto, and H.M. Shin, Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study, Environ. Int. 147 (2021), pp. 106328. doi:10.1016/j.envint.2020.106328.
   PubMed Web of Science ®Google Scholar
• J. Oh, R.J. Schmidt, D. Tancredi, A.M. Calafat, D.L. Roa, I. Hertz-Picciotto, and H.M. Shin, Prenatal exposure to per- and polyfluoroalkyl substances and cognitive development in infancy and toddlerhood, Environ. Res. 196 (2021), pp. 110939. doi:10.1016/j.envres.2021.110939.
   PubMed Web of Science ®Google Scholar
• C.R. Stein and D.A. Savitz, Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age, Environ. Health Perspect. 119 (2011), pp. 1466–1471. doi:10.1289/ehp.1003538.
   PubMed Web of Science ®Google Scholar
• A.M. Vuong, K. Yolton, G.M. Webster, A. Sjödin, A.M. Calafat, J.M. Braun, K.N. Dietrich, B.P. Lanphear, and A. Chen, Prenatal polybrominated diphenyl ether and perfluoroalkyl substance exposures and executive function in school-age children, Environ. Res. 147 (2016), pp. 556–564. doi:10.1016/j.envres.2016.01.008.
   PubMed Web of Science ®Google Scholar
• K. Hoffman, T.F. Webster, M.G. Weisskopf, J. Weinberg, and V.M. Vieira, Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12–15 years of age, Environ. Health Perspect. 118 (2010), pp. 1762–1767. doi:10.1289/ehp.1001898.
   PubMed Web of Science ®Google Scholar
• Z. Liew, B. Ritz, O.S.V. Ehrenstein, B.H. Bech, E.A. Nohr, C. Fei, R. Bossi, T.B. Henriksen, E.C. Bonefeld-Jørgensen, and J. Olsen, Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: A nested case–control study in the Danish national birth cohort, Environ. Health Perspect. 123 (2015), pp. 367–373. doi:10.1289/ehp.1408412.
   PubMed Web of Science ®Google Scholar
• M. Strøm, S. Hansen, S.F. Olsen, L.S. Haug, P. Rantakokko, H. Kiviranta, and T.I. Halldorsson, Persistent organic pollutants measured in maternal serum and offspring neurodevelopmental outcomes–a prospective study with long-term follow-up, Environ. Int. 68 (2014), pp. 41–48. doi:10.1016/j.envint.2014.03.002.
   PubMed Web of Science ®Google Scholar
• D.H. Kim, U.J. Kim, H.Y. Kim, S.D. Choi, and J.E. Oh, Perfluoroalkyl substances in serum from South Korean infants with congenital hypothyroidism and healthy infants–its relationship with thyroid hormones, Environ. Res. 147 (2016), pp. 399–404. doi:10.1016/j.envres.2016.02.037.
   PubMed Web of Science ®Google Scholar
• T.T. Schug, R. Abagyan, B. Blumberg, T.J. Collins, D. Crews, P.L. DeFur, S.M. Dickerson, T.M. Edwards, A.C. Gore, L.J. Guillette, T. Hayes, J.J. Heindel, A. Moores, H.B. Patisaul, T.L. Tal, K.A. Thayer, L.N. Vandenberg, J. Warner, C.S. Watson, F.S. Saal, R.T. Zoeller, K.P. O’Brien, and J.P. Myers, Designing endocrine disruption out of the next generation of chemicals, Green Chem. 15 (2013), pp. 181–198. doi:10.1039/c2gc35055f.
   PubMed Web of Science ®Google Scholar
• P. Catanuto, S. Doublier, E. Lupia, A. Fornoni, M. Berho, M. Karl, G.E. Striker, X. Xia, and S. Elliot, 17 β-estradiol and tamoxifen upregulate estrogen receptor β expression and control podocyte signaling pathways in a model of type 2 diabetes, Kidney Int. 75 (2009), pp. 1194–1201. doi:10.1038/ki.2009.69.
   PubMed Web of Science ®Google Scholar
• S.V. Dangudubiyyam, J.S. Mishra, H. Zhao, and S. Kumar, Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy increases blood pressure and impairs vascular relaxation mechanisms in the adult offspring, Reprod. Toxicol. 98 (2020), pp. 165–173. doi:10.1016/j.reprotox.2020.09.008.
   PubMed Web of Science ®Google Scholar
• X. Han, L. Meng, G. Zhang, Y. Li, Y. Shi, Q. Zhang, and G. Jiang, Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in east China, Environ. Int. 156 (2021), pp. 106637. doi:10.1016/j.envint.2021.106637.
   PubMed Web of Science ®Google Scholar
• R. Krysiak, B. Marek, and B. Okopień, Inhibitory effect of carbamazepine on hypotensive action of spironolactone in primary aldosteronism, Endokrynol. Pol. 60 (2009), pp. 52–55.
   PubMed Web of Science ®Google Scholar
• G. Pitter, M. Zare Jeddi, G. Barbieri, M. Gion, A.S.C. Fabricio, F. Daprà, F. Russo, T. Fletcher, and C. Canova, Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults, Environ. Health 19 (2020), pp. 102. doi:10.1186/s12940-020-00656-0.
   PubMed Web of Science ®Google Scholar
• Q. Sun, G. Zong, D. Valvi, F. Nielsen, B. Coull, and P. Grandjean, Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: A prospective investigation among U.S. women, Environ. Health Perspect. 126 (2018), pp. 037001. doi:10.1289/EHP2619.
   PubMed Web of Science ®Google Scholar
• J.E. Chambers, H. Greim, R.J. Kendall, H. Segner, R.M. Sharpe, and G. Van Der Kraak, Human and ecological risk assessment of a crop protection chemical: A case study with the azole fungicide epoxiconazole, Crit. Rev. Toxicol. 44 (2014), pp. 176–210. doi:10.3109/10408444.2013.855163.
   PubMed Web of Science ®Google Scholar
• T. Zhan, S. Cui, X. Liu, C. Zhang, Y.-M.M. Huang, and S. Zhuang, Enhanced disrupting effect of benzophenone-1 chlorination byproducts to the androgen receptor: Cell-based assays and gaussian accelerated molecular dynamics simulations, Chem. Res. Toxicol. 34 (2021), pp. 1140–1149. doi:10.1021/acs.chemrestox.1c00023.
   PubMed Web of Science ®Google Scholar
• H. Cho, H. Gim, H. Li, L. Subedi, S. Kim, J. Ryu, and R. Jeon, Structure–activity relationship of phytoestrogen analogs as ERα/β agonists with neuroprotective activities, Chem. Pharm. Bull. 69 (2021), pp. 99–105. doi:10.1248/cpb.c20-00706.
   PubMed Web of Science ®Google Scholar
• L. Amazit, F. Le Billan, P. Kolkhof, K. Lamribet, S. Viengchareun, M.R. Fay, J.A. Khan, A. Hillisch, M. Lombès, M.-E. Rafestin-Oblin, and J. Fagart, Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1*, J. Biol. Chem. 290 (2015), pp. 21876–21889. doi:10.1074/jbc.M115.657957.
   PubMed Web of Science ®Google Scholar
• P. Dufour, C. Pirard, P. Petrossians, A. Beckers, and C. Charlier, Association between mixture of persistent organic pollutants and thyroid pathologies in a Belgian population, Environ. Res. 181 (2020), pp. 108922. doi:10.1016/j.envres.2019.108922.
   PubMed Web of Science ®Google Scholar
• L. Torres-Sanchez, M. Zepeda, M.E. Cebrián, J. Belkind-Gerson, R.M. Garcia-Hernandez, U. Belkind-Valdovinos, and L. López-Carrillo, Dichlorodiphenyldichloroethylene exposure during the first trimester of pregnancy alters the anal position in male infants, Ann. N. Y. Acad. Sci. 1140 (2008), pp. 155–162. doi:10.1196/annals.1454.004.
   PubMed Web of Science ®Google Scholar
• H. Saiyed, A. Dewan, V. Bhatnagar, U. Shenoy, R. Shenoy, H. Rajmohan, K. Patel, R. Kashyap, P. Kulkarni, and B. Rajan, Effect of endosulfan on male reproductive development, Environ. Health Perspect. 111 (2003), pp. 1958–1962. doi:10.1289/ehp.6271.
   PubMed Web of Science ®Google Scholar
• H. Xu and Y. Bo, Associations between pyrethroid exposure and serum sex steroid hormones in adults: Findings from a nationally representative sample, Chemosphere 300 (2022), pp. 134591. 10.1016/j.chemosphere.2022.134591.
   PubMed Web of Science ®Google Scholar
• T. Mroz, K. Mroz, and P. Tutka, Androgens and epilepsy, Prz. Lek. 67 (2010), pp. 1186–1193.
   PubMedGoogle Scholar
• T. Jakubus, M. Michalska-Jakubus, K. Łukawski, A. Janowska, and S.J. Czuczwar, Atherosclerotic risk among children taking antiepileptic drugs, Pharmacol. Rep. 61 (2009), pp. 411–423. doi:10.1016/S1734-1140(09)70082-9.
   PubMed Web of Science ®Google Scholar
• B. Uzzan, D. Dumont-Fischer, N. Lahlou, H. Bihan, M.C. Boissier, J.C. Alvarez, G.Y. Perret, and R. Cohen, Factitious increases in serum testosterone concentrations related to phenylbutazone therapy, Fundam. Clin. Pharmacol. 22 (2008), pp. 159–160. doi:10.1111/j.1472-8206.2007.00564.x.
   PubMed Web of Science ®Google Scholar
• E.J. Giltay, C. Popp-Snijders, D. van Schaardenburg, B.J. Dekker-Saeys, L.J. Gooren, and B.A. Dijkmans, Serum testosterone levels are not elevated in patients with ankylosing spondylitis, J. Rheumatol. 25 (1998), pp. 2389–2394.
   PubMed Web of Science ®Google Scholar
• W. Cao, P. Yu, K. Yang, and D. Cao, Aflatoxin B1: Metabolism, toxicology, and its involvement in oxidative stress and cancer development, Toxicol. Mech. Methods 32 (2022), pp. 395–419. doi:10.1080/15376516.2021.2021339.
   PubMed Web of Science ®Google Scholar
• A. Ramírez Carnero, A. Lestido-Cardama, P. Vazquez Loureiro, L. Barbosa-Pereira, A. Rodríguez Bernaldo de Quirós, and R. Sendón, Presence of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in food contact materials (FCM) and its migration to food, Foods 10 (2021), pp. 1443. doi:10.3390/foods10071443.
   PubMed Web of Science ®Google Scholar
• J.L. Domingo and M. Nadal, Human exposure to per-and polyfluoroalkyl substances (PFAS) through drinking water: A review of the recent scientific literature, Environ. Res. 177 (2019), pp. 108648. doi:10.1016/j.envres.2019.108648.
   PubMed Web of Science ®Google Scholar
• Ş. Sungur, Dietary exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS): A review of recent literature, Toxin Rev. 37 (2018), pp. 106–116. doi:10.1080/15569543.2017.1346685.
   Web of Science ®Google Scholar
• M. Lorenzo, M. Farré, C. Blasco, M. Onghena, Y. Picó, and D. Barceló, Perfluoroalkyl substances in breast milk, infant formula and baby food from Valencian community (Spain), Environ. Nanotechnol. Monit. Manage. 6 (2016), pp. 108–115. 10.1016/j.enmm.2016.09.001.
   Google Scholar
• S.M. Bartell, A.M. Calafat, C. Lyu, K. Kato, P.B. Ryan, and K. Steenland, Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia, Environ. Health Perspect. 118 (2010), pp. 222–228. doi:10.1289/ehp.0901252.
   PubMed Web of Science ®Google Scholar
• X.Y. Ye, K. Kato, L.Y. Wong, T. Jia, A. Kalathil, J. Latremouille, and A.M. Calafat, Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013–2014, Int. J. Hyg. Environ. Health 221 (2018), pp. 9–16. doi:10.1016/j.ijheh.2017.09.011.
   PubMed Web of Science ®Google Scholar
• K. Kato, L.-Y. Wong, L.T. Jia, Z. Kuklenyik, and A.M. Calafat, Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999−2008, Environ. Sci. Technol. 45 (2011), pp. 8037–8045. doi:10.1021/es1043613.
   PubMed Web of Science ®Google Scholar
• S. Mondal, R. Das, and S.K. Chakrabarti, A new photometric survey design for detection of extra-solar planets by transit technique, AIP Conf. Proc. 1543 (2013), pp. 187–193. doi:10.1063/1.4812613.
   Google Scholar